Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Biogen Inc.(BIIB) | 643,000 | 643,000 | 0 | $138.65M | $149.06M | 25.16% | +$10.41M |
| Innoviva, Inc.(INVA) | 7,277,000 | 7,277,000 | 0 | $110.90M | $119.34M | 20.14% | +$8.44M |
| Ironwood Pharmaceuticals, Inc.CL A(IRWD) | 16,390,000 | 16,390,000 | 0 | $142.76M | $106.86M | 18.04% | -$35.89M |
| Gilead Sciences, Inc.(GILD) | 1,103,282 | 1,103,282 | 0 | $80.82M | $75.70M | 12.78% | -$5.12M |
| Cytokinetics, Incorporated(CYTK) | 300,000 | 1,110,000 | +810,000 | $21.03M | $60.14M | 10.15% | +$39.11M |
| Neurocrine Biosciences, Inc.(NBIX) | 346,426 | 410,483 | +64,057 | $47.78M | $56.51M | 9.54% | +$8.73M |
| Amarin Corp PlcADR | 24,850,623 | 24,850,623 | 0 | $22.14M | $17.10M | 2.89% | -$5.04M |
| BioCryst Pharmaceuticals, Inc.(BCRX) | 1,094,168 | 1,094,168 | 0 | $5.56M | $6.76M | 1.14% | +$1.20M |
| Vor Biopharma Inc.(VOR) | 618,000 | 618,000 | 0 | $1.46M | $618.0K | 0.10% | -$846.7K |
| Regulus Therapeutics Inc | 185,183 | 185,183 | 0 | $533.3K | $330.6K | 0.06% | -$202.8K |